Drug Enforcement Administration

News

Trump's DOJ reschedules medicinal marijuana, increasing acce...

The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.

News

SCOTUS backs generic firm Hikma in skinny label dispute

SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Drug Enforcement Administration

Editor's Picks